APA (7th ed.) Citation

Poljakova, J., Hrebackova, J., Dvorakova, M., Moserova, M., Eckschlager, T., Hrabeta, J., . . . Stiborova, M. (2011). Anticancer agent ellipticine combined with histone deacetylase inhibitors, valproic acid and trichostatin A, is an effective DNA damage strategy in human neuroblastoma. Neuroendocrinology letters, 32, .

Chicago Style (17th ed.) Citation

Poljakova, Jitka, et al. "Anticancer Agent Ellipticine Combined with Histone Deacetylase Inhibitors, Valproic Acid and Trichostatin A, Is an Effective DNA Damage Strategy in Human Neuroblastoma." Neuroendocrinology Letters 32 (2011).

MLA (9th ed.) Citation

Poljakova, Jitka, et al. "Anticancer Agent Ellipticine Combined with Histone Deacetylase Inhibitors, Valproic Acid and Trichostatin A, Is an Effective DNA Damage Strategy in Human Neuroblastoma." Neuroendocrinology Letters, vol. 32, 2011.